What’s Driving Growth in the Neurovascular Embolization Devices Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Anticipated CAGR of the Neurovascular Embolization Devices Market, and What Factors Will Drive It?
In recent times, the neurovascular embolization devices market has seen a significant expansion. The market is set to increase from a worth of $1.32 billion in 2024 to approximately $1.4 billion in 2025, with a compound annual growth rate (CAGR) standing at 6.2%. This impressive growth during the historical period can be linked to an uptick in neurovascular disorders, an aging population, a rising demand for less invasive procedures, enhancements in healthcare infrastructure, and a surge in healthcare spending.
Strong expansion is projected for the neurovascular embolization devices market in the upcoming years, with growth estimated to reach $1.8 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.5%. The predicted growth during the forecast period is due to factors such as the increasing application in emerging markets, a growing focus on patient-centric care, heightened awareness of neurovascular disorders, advancements in imaging technologies and heightened investment in research and development. Key forecast period trends encompass personalized treatment regimens, incorporation of artificial intelligence in treatment planning, the introduction of next-generation embolic materials, a shift to outpatient and ambulatory procedures and the evolution of novel embolization techniques.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Neurovascular Embolization Devices Market?
The increase in hemorrhage cases is anticipated to fuel the growth of the neurovascular embolization devices market. Hemorrhages refer to abnormal, unregulated internal or external bleeding, often resulting from a break in the skin or mucous membrane. Factors such as the growing elderly population, a rise in hypertension cases, and the broader application of anticoagulant medications contribute to the prevalence of hemorrhages. Neurovascular embolization devices are used during hemorrhagic strokes to block abnormal blood vessels, thus mitigating bleeding and averting additional brain damage. For example, a study conducted by King’s College London in February 2024 predicted a 59.4% rise in the number of intracerebral hemorrhage (ICH) cases and fatalities among individuals aged 70 to 95 within the UK by 2050. Consequently, the upsurge in hemorrhage cases serves as a key driver for the expansion of the neurovascular embolization devices market.
Get Your Free Sample of the Global Neurovascular Embolization Devices Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp
Who Are the Top Companies Contributing to the Growth of the Neurovascular Embolization Devices Market?
Major companies operating in the neurovascular embolization devices market are:
• Johnson & Johnson_x000D_
• Abbott Laboratories_x000D_
• Medtronic plc_x000D_
• Heraeus Holding_x000D_
• Stryker Corporation_x000D_
How Are Technological Trends Affecting the Growth and Development of the Neurovascular Embolization Devices Market?
Leading firms in the neurovascular embolization devices sector are prioritizing the creation of technologically advanced products, such as those featuring shield technology, with the aim of obtaining a competitive advantage in the market. Shield Technology is an innovative feature designed to improve the efficiency and safety of these devices, and to enhance their overall durability and lifespan. As an example, in June 2022, the healthcare technology firm Medtronic PLC, which is based in Ireland, launched the fourth generation Pipeline Vantage with Shield Technology in India. This flow diverter has improved design features for greater user-friendliness and reliability during endovascular procedures. The device aids in cell growth in the blood vessel’s inner lining, providing a structural support that helps in the less invasive treatment of aneurysms, reduces rupture risk, and improves patient recovery rates.
Get Instant Access to the Global Neurovascular Embolization Devices Market Report with Swift Delivery!
Which Growth-Oriented Segments of the Neurovascular Embolization Devices Market Are Leading the Industry’s Development?
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
What Are the Key Regions Powering Growth in the Neurovascular Embolization Devices Market?
North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Defining Features of the Neurovascular Embolization Devices Market?
Neurovascular embolization devices are medical instruments used to treat abnormal brain or central nervous blood vessels by blocking or redirecting blood flow. These devices are employed in neuro-interventional procedures to manage conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that may risk bleeding or other complications.
Browse Through More Similar Reports By The Business Research Company:
Uterine Fibroid Embolization Device Global Market Report 2024
Neurofibromatosis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report
Tumor Embolization Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
